PROTOCOLOS CLÍNICOS E DIRETRIZES TERAPÊUTICAS

Síndrome de Turner Síndrome de Turner 19. Carel JC, Elie C, Ecosse E, Tauber M, Léger J, Cabrol S, et al. Self-esteem and social adjustment in young women with Turner syndrome – influence of pubertal management and sexuality: population-based cohort study. J Clin Endocrinol Metab. 2006;91(8):2972-9. Epub 2006 May 23. 20. Bannink EM, van der Palen RL, Mulder PG, de Muinck Keizer-Schrama SM. Long-term follow-up of GH- treated girls with Turner syndrome: metabolic consequences. Horm Res. 2009;71(6):343-9. Epub 2009 Jun 9. 21. Bannink EM, van der Palen RL, Mulder PG, de Muinck Keizer-Schrama SM. Long-term follow-up of GH- treated girls with Turner syndrome: BMI, blood pressure, body proportions. Horm Res. 2009;71(6):336-42. Epub 2009 Jun 8. 22. Andersson-Wallgren G, Ohlsson AC, Albertsson-Wikland K, Barrenäs ML. Growth promoting treatment normalizes speech frequency in Turner syndrome. Laryngoscope. 2008;118(6):1125-30. 23. Chernausek SD, Attie KM Cara J, Rosenfeld RG, Frane J. Growth hormone therapy of Turner Syndrome: the impact of age of estrogen replacement on final height. J Clin Endocrinol Metab. 2000;85(7):2439-45. 24. Van Pareren YK, Keizer-Schrama SMPF, Stijnen T, sas TC, Jansen M, Otten BJ, et al. Final height in girls with Turner syndrome after long term growth hormone treatment in three dosages and low dose estrogens. J Clin Endocrinol Metab. 2003;88(3):1119-25. 25. National Institute for Clinical Excellence (NICE). Guidance on the use of human growth hormone (somatropin) in children with growth failure [Internet]. London: NICE; 2002 [cited 2010 May 21]. Available from: http://www. nice.org.uk/nicemedia/live/11458/32368/32368.pdf. 26. Lyon AJ, Preece MA, Grant DB. Growth curve for girls with Turner syndrome. Arch Dis Child. 1988;60(10):932-5. 27. Bettendorf M, Doerr HG, Hauffa BP, Lindberg A, Mehis O, Partsch CJ, et al. Prevalence of autoantibodies associated with thyroid and celiac disease in Ullrich-Turner syndrome in relation to adult height after growth hormone treatment. J Pediatr Endocrinol Metab. 2006;19(2):149-54. 28. Cutfield WS, Lundgren F. Insulin-like growth factor I and growth responses during the first year of growth hormone treatment in KIGS patients with idiopathic growth hormone deficiency, acquired growth hormone deficiency, turner syndrome and born small for gestational age. Horm Res. 2009;71(suppl 1):39-45. Epub 2009 Jan 21. 29. Drug facts and comparisons. 56th ed. St Louis (MO): Facts and Comparisons; 2002. 30. Bolar K, Hoffman AR, Maneatis T, Lippe B. Long-term safety of recombinant human growth hormone in turner syndrome. J Clin Endocrinol Metab. 2008;93(2):344-51. Epub 2007 Nov 13. 31. Van den Berg J, Bannink EM, Wielopolski PA, Pattynama PM, de Muinck Keizer-Schrama SM, Helbing WA. Aortic distensibility and dimensions and the effects of growth hormone treatment in the turner syndrome. Am J Cardiol. 2006;97(11):1644-9. Epub 2006 Apr 19. 567